Biovica International - Positive Results With DiviTum® From New Pfizer Study Presented at the AACR Congress

Corporate Breaking News

Home : Biovica International - Positive Results With DiviTum® From New Pfizer Study Presented at the AACR Congress

Apr 17 2018	Biovica International - Positive Results With DiviTum® From New Pfizer Study Presented at the AACR Congress
UPPSALA, Sweden, April 17, 2018 /PRNewswire/ -- New results from a Pfizer study on Ibrance® (palbociclib, Pfizer) of women with metastatic breast cancer demonstrate that DiviTum can provide fast evaluation of biologic effect demonstrating CDK 4/6 inhibition. The study, presented...


Source:https://www.prnewswire.com/news-releases/biovica-international---positive-results-with-divitum-from-new-pfizer-study-presented-at-the-aacr-congress-300631000.html

Related News
» NeuroVive's Partner Yungjin Pharm Completes KL1333 Phase I Study Recruitment » Wirecard's boon Mobile Payment Solution Now Available on Fitbit Pay